Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells
about
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncologyFumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage responseThe FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiencyThe mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenaseApplications of metabolomics in cancer researchState of the science: an update on renal cell carcinomaCancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexateSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsReactive oxygen species in cancer stem cellsPhysiological consequences of complex II inhibition for aging, disease, and the mKATP channelPancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersLinking metabolism and epigenetic regulation in development of hepatocellular carcinomaHIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epitheliumIDH mutations in tumorigenesis and their potential role as novel therapeutic targets.Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal CancerMetabolic consequences of oncogenic IDH mutationsTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesMetabolic modulation of glioblastoma with dichloroacetateObesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox BalancePronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104Novel isoenzyme of 2-oxoglutarate dehydrogenase is identified in brain, but not in heartGlioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alphaIron control of erythroid development by a novel aconitase-associated regulatory pathway.A novel strategy involved in [corrected] anti-oxidative defense: the conversion of NADH into NADPH by a metabolic network.Interrogating IDH Mutation in Brain Tumor: Magnetic Resonance and Hyperpolarization.The tricarboxylic acid cycle, an ancient metabolic network with a novel twist.Current views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaEmerging Metabolic Therapies in Pulmonary Arterial Hypertension.Succinate is an inflammatory signal that induces IL-1β through HIF-1α.Novel two-step derivation method for the synchronous analysis of inherited metabolic disorders using urine.Metabolism and the leukemic stem cell.Metabolic basis to Sherpa altitude adaptationThe expression and significance of IDH1 and p53 in osteosarcomaPotential therapeutic benefits of strategies directed to mitochondria.Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressorsThe metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR.Targeting histone lysine demethylases - progress, challenges, and the future2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process.Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex IIIntermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
P2860
Q21129303-BECDD5E6-2615-44D2-8583-EE24061C267FQ21145799-3E578755-4A1D-462D-AEC1-E76D02C4F5CDQ21261429-C87D068A-104A-4807-B588-B27E6DC1E282Q24294745-D69C746F-D5DD-4767-A010-B59CA1875C2AQ24600728-DAE82B4B-453D-4D0F-A711-AA9793A462A4Q24630685-305CA534-5F8B-41BC-9779-F575293FC2B2Q26775475-AAB8994F-A24B-48B5-80E6-6272942CCB79Q26796203-18495586-E979-44FB-88CD-EA75F1B368E6Q26849216-07123CA4-566D-4B47-B2C3-8DCCA00CECFDQ27002338-4D031289-1F0F-4350-8EF0-59F1C0A184C4Q27022231-C7029CBD-BFA5-448E-878E-DCA09350DDA2Q27023744-308EBC9F-EFC6-427F-A45E-8E6C7DD10FD5Q27316863-9BCF0A91-1BE8-4B3F-85B8-FD7CFDFA6586Q27692015-3A8E705C-8E07-4098-B5D0-41D32C5011F7Q28074285-30BF2449-9B23-4ED6-A242-E8298E743D93Q28082949-4FFC3B1D-E5D4-440F-A8A8-0DBD4D55B34FQ28085631-2A021C6B-4089-4C2A-81A7-5A465DF26D21Q28282255-EE17754A-3A8A-4EC3-9310-BC1AF6E86EBEQ28385322-99988C85-CEB5-4683-AC67-4EE3711E243FQ28741513-6600B96C-9827-456F-A311-CFDD09B74DDFQ29396800-F7456862-4562-4C2B-9C0E-FCD98A4C69AFQ29619709-F696BF45-F7A4-4B1A-865C-3495945DE9B0Q30431455-ACB32806-217C-49C7-B94C-126898FF3BA7Q30845183-AEEE64B8-67E2-4C2C-A72E-8FBA4C0C7A99Q31154376-1C58233D-0CE8-4A87-A49D-62D6EA685732Q33292692-1C15DC8B-4CC7-4077-90FB-98D3F77D242FQ33590969-106CC3A9-2862-4A71-9368-523B205247B8Q33608219-2D827AAF-8EDF-411E-97FB-74BF163C9412Q33652731-D61622D1-8273-45DE-9AFB-9B077FE0B122Q33723765-D8E5F20B-E369-4288-A1E5-BAC30015F966Q33795007-95CA8717-D9A9-4975-B0A7-927194F3C162Q33810317-D5BE4550-B6B8-43B3-88C9-44F4D1C79480Q33864108-8DD2E539-2B4C-47D1-8584-00E9B6C6F323Q34117168-FC07C21D-C4F0-44FF-A74E-1AADC1CABF21Q34279708-D7BA2539-187B-43EB-8A6A-83733284FDEFQ34419977-78E99714-C50D-4835-A6DA-8D9AC645B5C5Q34421279-81847DCD-BEA2-4295-914B-6538E17CC06FQ34482634-3AED0027-AC6C-4CCA-BB07-E646DC0464B7Q34536966-A06CFCD3-0E8E-457B-A810-54F4486CF1A8Q34566270-68B4883B-8834-43AA-B4D6-AB06D8C26A96
P2860
Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@ast
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@en
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@nl
type
label
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@ast
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@en
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@nl
prefLabel
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@ast
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@en
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@nl
P2093
P2860
P3181
P356
P1476
Cell-permeating alpha-ketoglut ...... dehydrogenase-deficient cells
@en
P2093
Casper M Frederiksen
David G Watson
Elaine D MacKenzie
Lloyd J Payne
Mary A Selak
Stuart Crosby
P2860
P304
P3181
P356
10.1128/MCB.01927-06
P407
P577
2007-05-01T00:00:00Z